Submitted by Anonymous (not verified) on 29 November 2024 - 15:22
Human medicines European public assessment report (EPAR): Lutetium (177Lu) chloride Billev (previously Illuzyce), lutetium (177Lu) chloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised
Source: